Home » Genzyme Launches Diagnosic to Boost Thyroid Cancer Drug, Despite Shortages
Genzyme Launches Diagnosic to Boost Thyroid Cancer Drug, Despite Shortages
Genzyme announced a nationwide launch of a new diagnostic to help detect thyroid cancer. The genomic test, called Afirma, is produced by Veracyte, a San Francisco-based molecular diagnostics company.
Boston Business Journal
Boston Business Journal
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May